Alkemy Capital Investments PLC Appointment of SI Capital as Corporate Broker (0676F)
05 Julio 2023 - 5:00AM
UK Regulatory
TIDMALK
RNS Number : 0676F
Alkemy Capital Investments PLC
05 July 2023
5 July 2023
Alkemy Capital Investments Plc
Appointment of SI Capital as Corporate Broker
Alkemy Capital Investments plc ("Alkemy") (ALK:LSE) (JV2:FRA) is
pleased to announce the appointment of SI Capital as a broker to
the Company.
SI Capital is a specialist full-service stockbroker and member
of the London Stock Exchange, based in Surrey and London's Mayfair,
offering fully integrated Corporate Broking, Research and
Investment Advisor capabilities.
Further information
For further information, please visit Alkemy's website:
www.alkemycapital.co.uk or TVL's website
www.teesvalleylithium.co.uk .
-Ends-
Alkemy Capital Investments Plc Tel: 0207 317 0636
info@alkemycapital.co.uk
SI Capital Limited Tel: 0148 341 3500
VSA Capital Limited Tel: 0203 005 5000
NOTES TO EDITORS
Alkemy is seeking to establish the world's leading independent
and sustainable lithium hydroxide production by developing
state-of-the-art lithium sulphate and lithium hydroxide facilities
in Australia and the UK.
Alkemy, through its wholly-owned subsidiary Tees Valley Lithium,
has secured a 9.6 ha brownfields site with full planning permission
at the Wilton International Chemicals Park in Teesside, a major UK
Freeport, to build the UK's first and Europe's largest lithium
hydroxide processing facility.
Tees Valley Lithium has completed a Class 4 Feasibility Study
for its proposed lithium hydroxide refinery which will process
feedstock imported from various sources to produce 96,000 tonnes of
premium, low-carbon lithium hydroxide annually, representing around
15% of Europe's projected demand.
Alkemy has also secured a site near Port Hedland, Western
Australia to build a world-class sustainable lithium sulphate
refinery that will provide reliable feedstock for Tees Valley
Lithium.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
APPDZGGNLKRGFZG
(END) Dow Jones Newswires
July 05, 2023 06:00 ET (10:00 GMT)
Alkemy Capital Investments (LSE:ALK)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Alkemy Capital Investments (LSE:ALK)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024